179 related articles for article (PubMed ID: 4009611)
1. Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridines.
Kaminski JJ; Bristol JA; Puchalski C; Lovey RG; Elliott AJ; Guzik H; Solomon DM; Conn DJ; Domalski MS; Wong SC
J Med Chem; 1985 Jul; 28(7):876-92. PubMed ID: 4009611
[TBL] [Abstract][Full Text] [Related]
2. Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analogues.
Kaminski JJ; Hilbert JM; Pramanik BN; Solomon DM; Conn DJ; Rizvi RK; Elliott AJ; Guzik H; Lovey RG; Domalski MS
J Med Chem; 1987 Nov; 30(11):2031-46. PubMed ID: 3669011
[TBL] [Abstract][Full Text] [Related]
3. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
Kaminski JJ; Wallmark B; Briving C; Andersson BM
J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
[TBL] [Abstract][Full Text] [Related]
4. Antiulcer agents. 3. Structure-activity-toxicity relationships of substituted imidazo[1,2-a]pyridines and a related imidazo[1,2-a]pyrazine.
Kaminski JJ; Perkins DG; Frantz JD; Solomon DM; Elliott AJ; Chiu PJ; Long JF
J Med Chem; 1987 Nov; 30(11):2047-51. PubMed ID: 3669012
[TBL] [Abstract][Full Text] [Related]
5. Antiulcer agents. 4. Conformational considerations and the antiulcer activity of substituted imidazo[1,2-a]pyridines and related analogues.
Kaminski JJ; Puchalski C; Solomon DM; Rizvi RK; Conn DJ; Elliott AJ; Lovey RG; Guzik H; Chiu PJ; Long JF
J Med Chem; 1989 Aug; 32(8):1686-700. PubMed ID: 2754693
[TBL] [Abstract][Full Text] [Related]
6. Gastric antisecretory and cytoprotective activities of SCH 28080.
Long JF; Chiu PJ; Derelanko MJ; Steinberg M
J Pharmacol Exp Ther; 1983 Jul; 226(1):114-20. PubMed ID: 6864535
[TBL] [Abstract][Full Text] [Related]
7. Computer-automated structure evaluation of gastric antiulcer compounds: study of cytoprotective and antisecretory imidazo[1,2-a]pyridines and -pyrazines.
Klopman G; Srivastava S
Mol Pharmacol; 1990 Jun; 37(6):958-65. PubMed ID: 2359407
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of 3-substituted imidazo[1,2-a]pyridines as antiulcer agents.
Starrett JE; Montzka TA; Crosswell AR; Cavanagh RL
J Med Chem; 1989 Sep; 32(9):2204-10. PubMed ID: 2769690
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanisms of the antisecretory and cytoprotective actions of SCH 28080.
Chiu PJ; Casciano C; Tetzloff G; Long JF; Barnett A
J Pharmacol Exp Ther; 1983 Jul; 226(1):121-5. PubMed ID: 6306218
[TBL] [Abstract][Full Text] [Related]
10. Bicyclic compounds with potential antiulcer and/or antisecretory activity. I. 4,5,6,7-Tetrahydrobenzimidazoles.
Scarponi U; Cimaschi R; Rusconi L; Santangelo F; Arcari G; Castello R; Toti D; de Castiglione R
Farmaco Sci; 1985 Nov; 40(11):818-32. PubMed ID: 2867933
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of gastroprotective and antiulcer activity of some 2-substituted-1H-imidazo[4,5-b] pyridines and -1H-benzimidazoles.
Loriga M; Paglietti G; Piras S; Sparatore F; Anania V; Demontis MP; Varoni MV; Fattaccio MC
Farmaco; 1992 Mar; 47(3):287-303. PubMed ID: 1503593
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antisecretory activity of 6-substituted 5-cyanomethylimidazo[2,1-b]thiazoles and 2,6-dimethyl-5-hydroxymethylimidazo[2,1-b][1,3,4]thiadiazole.
Andreani A; Leoni A; Locatelli A; Morigi R; Rambaldi M; Simon WA; Senn-Bilfinger J
Arzneimittelforschung; 2000 Jun; 50(6):550-3. PubMed ID: 10918949
[TBL] [Abstract][Full Text] [Related]
13. Antiulcer agents. 6. Analysis of the in vitro biochemical and in vivo gastric antisecretory activity of substituted imidazo[1,2-a]pyridines and related analogues using comparative molecular field analysis and hypothetical active site lattice methodologies.
Kaminski JJ; Doweyko AM
J Med Chem; 1997 Feb; 40(4):427-36. PubMed ID: 9046332
[TBL] [Abstract][Full Text] [Related]
14. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.
Sanfilippo PJ; Urbanski M; Press JB; Hajos ZG; Shriver DA; Scott CK
J Med Chem; 1988 Sep; 31(9):1778-85. PubMed ID: 2842503
[TBL] [Abstract][Full Text] [Related]
16. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
17. Effects of a gastric antisecretory-cytoprotectant 2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile (Sch 28 080) on cysteamine, reserpine and stress ulcers in rats.
Chiu PJ; Gerhart C; Brown AD; Barnett A
Arzneimittelforschung; 1984; 34(7):783-6. PubMed ID: 6594140
[TBL] [Abstract][Full Text] [Related]
18. Studies on antiulcer drugs. III. Synthesis and antiulcer activities of imidazo[1,2-a]pyridinylethylbenzoxazoles and related compounds. A novel class of histamine H2-receptor antagonists.
Katsura Y; Inoue Y; Nishino S; Tomoi M; Itoh H; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1424-38. PubMed ID: 1356641
[TBL] [Abstract][Full Text] [Related]
19. Studies on antiulcer drugs. IV. Synthesis and antiulcer activities of imidazo[1,2-a]pyridinylethylbenzothiazoles and -benzimidazoles.
Katsura Y; Inoue Y; Nishino S; Tomoi M; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1818-22. PubMed ID: 1356644
[TBL] [Abstract][Full Text] [Related]
20. Effects of SCH 32651 on resting and stimulated acid secretion in guinea-pig isolated fundic mucosa.
Barnett A; Chiu PJ; Tetzloff G
Br J Pharmacol; 1984 Sep; 83(1):75-82. PubMed ID: 6091829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
